KRT8P26: A Potential Drug Target and Biomarker (G390211)

Target Name: KRT8P26

NCBI ID: G390211

KRT8P26

Other Name(s): Keratin 8 pseudogene 26 | keratin 8 pseudogene 26

KRT8P26: A Potential Drug Target and Biomarker

Keratin 8 pseudogene 26 (KRT8P26) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to investigate, and recent studies have shed light on its potential implications as a therapeutic agent.

KRT8P26 is a member of the Keratin gene family, which is responsible for the production of the proteins that make up the hair and nails. It has been identified in various organisms, including humans, and has been shown to play a role in the development and maintenance of these structures.

One of the defining features of KRT8P26 is its unique structure. It is a small RNA molecule that contains only 18 amino acid residues and consists of a single exon. Its minimal length and simple structure suggest that it is likely to be involved in a specific process or protein-protein interaction, and its unique 5' end may be involved in this interaction.

KRT8P26 has been shown to be involved in various cellular processes, including cell growth, differentiation, and apoptosis. It has been shown to play a role in regulating cell cycle progression, and has been shown to interact with several key cellular signaling pathways, including the TGF-β pathway.

In addition to its role in cellular processes, KRT8P26 has also been shown to be involved in the development of diseases. Studies have shown that KRT8P26 is overexpressed or underrepresented in various diseases, including cancer, and that its expression levels can be used as a biomarker for disease diagnosis and prognosis.

One of the potential benefits of KRT8P26 as a drug target is its small size and simple structure, which makes it relatively easy to modify and target. This has led to a great deal of interest in developing small molecule inhibitors of KRT8P26, which could be used to treat various diseases.

In addition to its potential as a drug target, KRT8P26 has also been shown to be a potential biomarker. Its unique structure and function make it an attractive candidate for use as a diagnostic or prognostic marker in various diseases.

Overall, KRT8P26 is a fascinating molecule that has the potential to be a drug target and biomarker in various diseases. Further research is needed to fully understand its role in these processes and to develop effective treatments based on its unique properties.

Protein Name: Keratin 8 Pseudogene 26

The "KRT8P26 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT8P26 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets